MCIC.US Multicorp Intl Inc.
- Market cap
- USD 912K
- P/E
- -
- P/B
- -
- ROE
- -6.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MCIC.US undervalued?
Graham numberThe Graham number of Multicorp Intl Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Multicorp Intl Inc. fundamental analysis
No fundamental analysis for Multicorp Intl Inc. yet.
Multicorp Intl Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Multicorp Intl Inc.
MultiCorp International, Inc. engages in medical business in the United States. It offers health care and technology services. The company was formerly known as XTend Medical Corporation and changed its name to MultiCorp International, Inc. in August 2012. The company was incorporated in 2002 and is based in Agoura Hills, California.
Full company profileMulticorp Intl Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Multicorp Intl Inc. annual financial statements
| Item | 2011 | 2013 | 2014 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 1.28M | 642K | - | - | - | - | - | - | - | - |
| Gross Profit | 0.00 | 1.28M | 642K | - | - | - | - | - | - | - | - |
| Operating Income | -15.6K | 614K | 627K | -400K | -299.00 | -60.0K | -56.0K | -44.6K | -27.0K | -6.70K | -280K |
| EBITDA | - | - | 642K | -400K | -299.00 | -60.0K | -56.0K | -44.6K | -27.0K | -6.70K | -280K |
| Net Income | -15.6K | 612K | 458K | -400K | -299.00 | -60.6K | -59.0K | -52.5K | -35.5K | -25.7K | -286K |
| EPS | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 695K | 20.1K | 442K | 552.00 | 307K | 8.87K | 2.15K | 196K | 192K | 5.19M | 5.00M |
| Total Liabilities | 295K | 46.4K | 8.91K | - | - | 69.2K | 122K | 368K | 399K | 423K | 449K |
| Shareholders' Equity | 400K | -26.4K | 433K | 552.00 | 307K | -60.4K | -119K | -172K | -207K | 4.77M | 4.55M |
| Cash & Short-term Investments | 162.00 | 3.06K | 10.8K | 552.00 | 552.00 | 8.87K | 2.15K | 6.35K | 2.03K | 27.70 | 1.71K |
| Total Debt | - | - | 8.91K | - | - | 68.7K | 118K | 354K | 374K | 386K | 404K |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | 627K | 473K | - | - | -60.0K | -56.0K | -232K | -24.3K | -14.3K | -21.5K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 5.00 | 0.00 | 6.67 |
| Free Cash Flow | - | - | 473K | - | - | -60.1K | -56.0K | -232K | -24.3K | -14.3K | -21.5K |
| Ratios | |||||||||||
| ROE | -3.9% | - | 105.9% | -72,463.8% | -0.1% | - | - | - | - | -0.5% | -6.3% |
| ROA | -2.2% | 3,051.2% | 103.7% | -72,463.8% | -0.1% | -683.3% | -2,740.0% | -26.8% | -18.5% | -0.5% | -5.7% |
| Net Profit Margin | - | 47.7% | 71.4% | - | - | - | - | - | - | - | - |
| Debt to Equity | - | - | 0.02x | - | - | - | - | - | - | 0.08x | 0.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Multicorp Intl Inc. dividends
Multicorp Intl Inc. has not paid dividends in the last 9 fiscal years.
Last stock split: 1.1:1 on Feb 15, 2008.
Who owns Multicorp Intl Inc.
Ownership data of Multicorp Intl Inc. is not available yet.
Multicorp Intl Inc. company profile
- Company name
- Multicorp Intl Inc.
- Ticker
- MCIC.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 5308 Derry Avenue, Agoura Hills, CA, United States, 91301
- Phone
- 818-262-6222
- Website
- multicorpinternational.com
About Multicorp Intl Inc.
MultiCorp International, Inc. engages in medical business in the United States. It offers health care and technology services. The company was formerly known as XTend Medical Corporation and changed its name to MultiCorp International, Inc. in August 2012. The company was incorporated in 2002 and is based in Agoura Hills, California.
Multicorp Intl Inc. management
5- Mr. Paul D. LisenbyExecutive Chairman
- Mr. David GustafsonInterim Chief Executive Officer
- Mr. Ben FriedmanPresident and Director
- Mr. Tony PlattChief Marketing Officer
- Mr. Kia MohammadiChief Risk Officer